Jfs Wealth Advisors, LLC Akero Therapeutics, Inc. Transaction History
Jfs Wealth Advisors, LLC
- $1.69 Billion
- Q3 2025
A detailed history of Jfs Wealth Advisors, LLC transactions in Akero Therapeutics, Inc. stock. As of the latest transaction made, Jfs Wealth Advisors, LLC holds 1 shares of AKRO stock, worth $54. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1Holding current value
$54% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding AKRO
# of Institutions
300Shares Held
92.1MCall Options Held
1.69MPut Options Held
874K-
Janus Henderson Group PLC London, X06.74MShares$365 Million0.19% of portfolio
-
General Atlantic LLC New York, NY5.73MShares$310 Million10.64% of portfolio
-
Black Rock Inc. New York, NY5.59MShares$302 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY5.48MShares$297 Million4.49% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.53MShares$245 Million0.0% of portfolio
About Akero Therapeutics, Inc.
- Ticker AKRO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,417,600
- Market Cap $2.51B
- Description
- Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regula...